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Abstract Manganese (Mn) is an essential trace element
required for ubiquitous enzymatic reactions. Chronic over-
exposure to this metal may promote potent neurotoxic
effects. The mechanism of Mn toxicity is not well estab-
lished, but several studies indicate that oxidative stress play
major roles inthe Mn-induced neurodegenerative processes.
Silymarin (SIL) has antioxidant properties and stabilizes
intracellular antioxidant defense systems. The aim of this
studywastoevaluatethetoxiceffectsofMnCl2onthemouse
neuroblastoma cell lines (Neuro-2A), to characterize the
toxic mechanism associated with Mn exposure and to
investigate whether SIL could efﬁciently protect against
neurotoxicity induced by Mn. A signiﬁcant increase in LDH
release activity was observed in Neuro-2A cells associated
with a signiﬁcant decrease in cellular viability upon 24 h
exposure to MnCl2 at concentrations of 200 and 800 lM
(P\0.05) when compared with control unexposed cells. In
addition, exposure cells to MnCl2 (200 and 800 lM),
increases oxidant biomarkers and alters enzymatic and non
enzymatic antioxidant systems. SIL treatment signiﬁcantly
reduced the levels of LDH, nitric oxide, reactive oxygen
species and the oxidants/antioxidants balance in Neuro-2A
cells as compared to Mn-exposed cells. These results sug-
gested that silymarin is a powerful antioxidant through a
mechanismrelatedtoitsantioxidantactivity,abletointerfere
with radical-mediated cell death. SIL may be useful in dis-
easesknowntobeaggravatedbyreactiveoxygenspeciesand
in the development of novel treatments for neurodegenera-
tive disorders such as Alzheimer or Parkinson diseases.
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Introduction
Chronic environmental or occupational exposure to man-
ganese (Mn) in mammals is identiﬁed as a dystonic neu-
rodegenerative movement disorders that results from
excessive accumulation of Mn in multiple brain regions
and presents with neurologic symptoms resembling feature
of Parkinson diseases [1]. Mn exposure can cause motor
deﬁcits in mammals that are characterized by extrapyra-
midal motor abnormalities, such as rigidity, hypokinesia,
tremor, and behavioural disturbances [2]. Although the
pathological changes and symptoms of Mn exposure are
well known, the primary mechanisms of neurotoxicity have
yet to be established. Several mechanisms of Mn neuro-
toxicity have been proposed, including disruption of
mitochondrial metabolism [3], disturbance of neurotrans-
mitter metabolism [4], alteration of iron homeostasis [5]
and induction of oxidative stress via direct or indirect
formation of free radicals in both neurons and astrocytes
[6–8]. Upon entering cells via facilitated diffusion and
receptor-gated cation channels [9], Mn avidly accumulates
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electron transport chain [11], which impairs oxidative
phosphorylation and ATP production [12]. The resulting
decreased energy production and alters mitochondrial
permeability transition, leading to excessive Ca
2? inﬂux
and massive reactive oxygen species (ROS) production
[13]. Moreover, superoxide, produced in the mitochondrial
electron transport chain (ETC.) [14], may catalyze the
transition shift of Mn
2?–Mn
3? through a set of reactions
similar to those mediated by superoxide dismutase and thus
lead to the increased oxidant capacity of this metal [15].
Knowing that oxidative stress plays a central role in Mn-
induced neurotoxicity, several authors have investigated
the potential neuroprotective effect of antioxidants against
Mn-induced toxicity. In mitochondrial preparations,
N-acetylcysteine (NAC), glutathione, and vitamin C pre-
vent ROS production caused by high concentrations of Mn
[16]. In cultured astrocytes, Chen and Liao [17] observe
that NAC attenuates the pro-oxidant effects of Mn.
Ex vivo, Hazell et al. [18] report that NAC blocks the
astrocytosis caused by acute exposure to Manganese.
Though several synthetic antioxidants are available, a
growing trend has been targeted toward the use of natural
products (polyphenols, ﬂavonoids, vitamins, carotenes and
lycopenes)asantioxidantsinviewoftoxicitycondemn[19].
Bioﬂavonoids are the ubiquitous group of polyphenolic
substancesthatarepresentinmostplants[20].Silymarinisa
ﬂavonoidisolatedfromthefruitsandseedsofthemilkthistle
(S. marianum). It is classiﬁed as a benzopyranone [21]
consistingofamixtureofpolyphenolicﬂavonoidlikesilibin,
isosilybin, silydianinand silychristin. It has been reportedto
possess multiple pharmacological activities and considered
as an anti-hepatotoxic agent for the treatment of various
diseases [22]. In addition several recent studies have shown
the potential hepatopreventive and therapeutic efﬁcacy of
silymarinindifferentanimalmodelsandcellculturesystems
[23, 24]. Its positive effects have been ascribed to the puta-
tive anti-oxidant, anti-inﬂammatory and anti-proliferative
properties based on the modulation of speciﬁc signalling
pathway, transcription factor and gene expression [25]. But
itspotentialprotectionforcentralnervoussystem(CNS)and
the mechanisms of action are still unclear.
In the current study, we established the mechanism of
SIL-mediated attenuation of reactive oxygen species (ROS)
generation and the possible involvement of its neuropro-
tection against Mn toxicity. The preventive effect of si-
lymarin against oxidative stress promoted by Mn was
studied by assessing biochemical parameters in Neuro-2A
cell, in order to evaluate enzymatic antioxidant defenses,
hydrogen peroxide content, glutathione redox, lipid perox-
idation and protein carbonyl content. We further addressed
whether the neuroprotective effects of SIL against Mn
toxicity were mediated via their antioxidant properties.
Materials and Methods
Materials
Lactate deshydrogenase (LDH) kit was purchased from
Biomaghreb ref. 20012 (Ariana, Tunis, Tunisia). Minimum
Essential Medium (MEM) was purchased from Invitrogen
(Glasgow, UK), foetal bovine serum (FBS) was provided
by Gibco (Invitrigen, USA). 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide (MTT), 5,50-dithi-obis-
(2-nitrobenzoic acid) (DTNB), Silymarin and all other
chemical products used in this study were obtained from
Sigma Chemical Co. (St. Louis, France). Culture plates and
ﬂasks were purchased from IWAKI (Japan).
Cell Culture
Neuro-2A mouse neuroblastoma cell line, obtained from
the ATCC (CCL-131), was routinely grown in 75 cm
2
ﬂasks and maintained in MEM supplemented with 10%
FBS, 3,500 units/ml polymyxin B sulfate, 1,400 units/ml
neomycine sulfate and 7.5 mg/ml streptomycin base. Cul-
tures were maintained in a humidiﬁed atmosphere with 5%
CO2 at 37C. Cell dissociation was achieved with 0.05%
trypsin-0.02% verse ´ne (triplex III). Brieﬂy, cells were
seeded on 96, 24 and 6-well culture plates in medium at an
approximate density of 1 9 10
5 cells/ml. After 24 h sta-
bilization, neuronal cells were co-cultured with medium
containing various concentrations of MnCl2 (200 and
800 lM) and/or silymarin (10, 50, and 100 lM) for 24 h.
The concentration of MnCl2 was selected based on previ-
ously reported cytotoxic levels in cultured cells [26]. For
stock solution, MnCl2 was dissolved in MilliQ Plus ster-
ilized water at the concentration of 800 mM. Silymarin was
dissolved in dimethylsulfoxide (DMSO) to obtain 100 mM.
The experimental concentrations were freshly prepared in
the basal medium with a ﬁnal DMSO concentration 0.1%.
Cell Viability Assay and Morphological Assessment
in Neuro-2A Cells
Cell viability was determined colorimetrically using the
MTT reduction assay. Neuro-2A cells were seeded in
96-well plate (1 9 10
5 cells/well) for 24 h and were
exposed following the above cell treatment protocol.
Brieﬂy, at the end of treatment, 10 ll of MTT [5 mg/ml in
phosphate buffered saline (PBS)] solution were added to
each well and the plates were incubated at 37C for addi-
tional 4 h. Then, the medium containing MTT was
removed and 200 ll of DMSO was added to each well to
achieve solubilization of the formazan crystal formed in
viable cells. The absorbance was read at 570 nm with
DMSO used as the blank. Cell viability was expressed as a
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123percentage of the control culture. Changes on the cell
morphology were observed with an Olympus model (CK2,
Japan) inverted phase-contrast microscope ﬁtted with a
digital camera to capture images.
LDH Assay
Membrane integrity was evaluated by measuring the LDH
activity in the culture medium of control and treated cells.
After 24 h treatment, the culture medium was removed and
the LDH activity was measured following the manufac-
turer’s protocol (Biomagreb, ref. 20012 Ariana, Tunis,
Tunisia). The percent of LDH activity released was
determined as percent of enzyme activity in the incubation
medium to the total LDH activity. The absence of the
viable cells corresponds to 100% of LDH activity in the
incubation medium.
Measurement of Intracellular ROS
The production of intracellular ROS was assessed by 20,70-
dichloroﬂuorescin diacetate (DCFDA) oxidation. Twenty-
four hours after treatment with SIL and/or Mn, cells were
incubated with 20 lM DCFH-DA at 37C for 1 h and
washed twice with PBS. The ﬂuorescence intensity of DCF
was measured in a microplate-reader at an excitation
wavelength of 485 nm and an emission wavelength of
530 nm. Results were expressed as percentage of controls.
Measurement of Cellular H2O2
The H2O2 concentration was measured in Neuro-2A
by a modiﬁcation of the ferrous oxidation-xylenol orange
(FOX1 reagent) assay adapted to microtiter plates [27, 28].
50 ll of Neuro-2A cells (1.0 9 10
6 cells/ml) were added to
950 ll of FOX 1 reagent and incubated for 30 min at room
temperature. This assay is based on the ability of H2O2 to
oxidize the ferrous Fe
2?-ions to the ferric Fe
3?-ions which
react with xylenol orange to a coloured complex. The
absorbance of the samples was read at 570 nm and the
concentration of H2O2 was determined using standard
peroxide solutions in the same microtiter plate.
Determination of Stress Markers and Antioxidant
Enzymes
Preparation of the Cellular Extracts
After the different treatments, Neuro-2A cells were tryp-
sinized and harvested. The pellets obtained after centrifu-
gation (2 min, 1.500 rpm, 4C) were resuspended and
washed twice in isotonic Tris-HCl buffer (20 mM, pH 7.4).
Cells suspension was lysed by 5 freeze-thaw cycles (liquid
nitrogen -37C). After centrifugation of the lysates at
8.0009g for 10 min at 4C they were stored at -80C,
until analysis.
Assay of Antioxidant Enzymes
Catalase (CAT) activity was assayed by the decomposition
of hydrogen peroxide according to the method of Aebi [29].
A decrease in absorbance due to H2O2 degradation was
monitored at 240 nm for 1 min and the enzyme activity was
expressed as lmol H2O2 consumed/min/mg protein.
Superoxide dismutase SOD (MnSOD and Cu/ZnSOD)
activities were evaluated by measuring the inhibition of
pyrogallol activity as described by Marklund and Marklund
[30]. Based on the competition between pyrogallol oxida-
tion by superoxide radicals and superoxide dismutation by
SOD. The speciﬁc Cu/Zn-SOD inhibition by potassium
cyanide allowed the Mn-SOD determination in the same
conditions. Assays were monitored by spectrophotometry
at 420 nm. One unit (U) corresponded to the enzyme
activity required to inhibit the half of pyrogallol oxidation.
SOD activity was expressed as U/mg protein.
Glutathione peroxidase (GPx) activity was measured
according to Flohe and Gunzler [31]. The enzyme activity
was expressed as nmoles of GSH oxidized/min/mg protein.
Assays of Oxidant Markers
Thiol,Disulﬁde(SH/SSRedoxState)andGSHAssays Thiols
(SH) and disulﬁdes (SS) were determined according to
ZahlerandCleland[32].Themethodisbasedonthereaction
of DTNB with the samples producing a yellow product,
thionitrobenzoic acid (TNB). The disulﬁde content was
calculated through the difference between the two determi-
nations. The SH/S-S ratio was also calculated. Results were
expressed as nmol TNB/mg protein.
Total Cellular Glutathione (GSH) levels were deter-
mined as described previously by Fairbanks and Klee [33].
Distilled water was used as blank and standards were
prepared from GSH. The slope of the reaction rate was
used to calculate the GSH content.
Lipid Peroxidation End Products and Protein Carbonyl
Assays The extend of lipid peroxidation in Neuro-2A cell
homogenates, was determined by measuring the release of
thiobarbituric acid reactive substance (TBARS) in terms of
malondialdehyde (MDA) formation according to Draper
and Hadley method [34]. Results were expressed as nmol
of MDA/mg of cellular protein.
The protein carbonyl PCO content of Neuro-2A
homogenates was determined according to the method of
Evans et al. [35]. Results were expressed as nmol DNPH
conjugated/mg protein.
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?-K
?-ATPase and Ca
2?-ATPase Activities
Na
?-K
?-ATPase and Ca
2?-ATPase were measured as
previously described [16, 36]. The inorganic phosphate–
molybdate complex was quantitated by spectrophotometer
at 690 nm. The Na
?-K
?-ATPase activity was calculated as
the difference between the total ATPase activity and the
ATPase activity inhibited by ouabain, the speciﬁc-inhibitor
of Na
?-K
?-ATPase. In the presence of Ca
2?,C a
2?-
ATPase activity appeared and was measured in the pres-
ence of Ca
2?,N a
?,K
?,M g
2? ions and ouabain. The
ATPase activity was expressed as lmol Pi/hour/mg of
protein.
Measurement of Nitrite, Tumor Necrosis Factor a
(TNFa) and Interleukin 6 (IL-6)
Neuro-2A cells were seeded on 24-well plates. After being
treated with SIL and/or Mn, the supernatants were col-
lected and stored at -80C until assays. As an indicator of
nitric oxide production, the amount of nitrite accumulated
in culture supernatant was determined with a colorimetric
assay using Griess reagent as previously described [37].
The concentration of nitrite in samples was determined
using a sodium nitrite standard curve.
TNFa and IL-6 levels were detected by mouse TNFa
and IL-6 enzyme-linked immunosorbent assay sandwich
method (ELISA) kits according to the procedures provided
by the manufacturers. Microtiter (96-well) plates were
coated with anti-mouse IL-6 and TNF-a (BD Pharmingen)
in coating buffer at 4C overnight. After the plates were
blocked and washed, 100 ll supernatant was added, and
plates were incubated for 1 h at room temperature. The
plates were then washed and treated with biotinylated
antibodies against IL-6 and TNF-a, then Extravidin—per-
oxidase conjugate (Sigma). A standard curve generated by
using puriﬁed recombinant IL-6, and TNF-a was used to
determine cytokine concentration.
Protein Assay
The protein concentration was determined using the
BCA
TM Bicinchoninic acid protein assay kit (Pierce Bio-
technology, Rockford, IL, USA) with bovine serum albu-
min as a standard.
Statistical Analysis
Results were expressed as mean ± standard deviation
(mean ± SD). All analysis was carried out with GraphPad
Prism 4.02 for Windows (GraphPad Software, San Diego,
CA). Signiﬁcant differences between treatment effects
were determined by 1-way ANOVA, followed by Tukey’s
post-hoc test for multiple comparisons with statistical sig-
niﬁcance of P\0.05.
Results
Protective Effect of SIL on Mn-Induced Toxicity
in Neuro-2A Cells
To determine the toxic effect of Mn, the cell viability and
cell membrane damage were analysed by MTT and LDH
release assay, respectively. Cytotoxicity was proportionally
enhanced with increased Mn concentrations (200 and
800 lM). As illustrated in Fig. 1a, the viability of cells
treated with 200 and 800 lM MnCl2 for 24 h showed a
signiﬁcant dose-dependent decrease (P\0.05) compared
to control group. As shown in Fig. 1b, cells treated with the
same doses induced signiﬁcant increase (P\0.05) of the
LDH level in the culture medium indicative of over
cytotoxicity.
The effect of SIL on Mn-induced toxicity was investi-
gated by testing three concentrations of the ﬂavonoid (10,
50 and 100 lM). The treatment of Neuro-2A cells with SIL
alone (10 and 50 lM) showed no toxicity after 24 h of
exposure. However, the highest concentration of SIL
(100 lM) did not provide signiﬁcantly greater antioxidant
activity than 50 lM, and the culture began to exhibit signs
of toxicity with signiﬁcant reduction (P\0.05) in cell
viability compared to that of control. These data showed a
dose-dependent effect of SIL with 50 lM evoking the
greatest protection against Mn toxicity. Based on those
results, this concentration was used in subsequent studies to
determine the neuroprotective effects against Mn toxicity.
In addition, we observed the effect of SIL on mor-
phology in Neuro-2A cells treated with Mn. As shown in
Fig. 1c, under phase contrast microscopy, untreated Neuro-
2A cells were long fusiform in shape with slender pro-
cesses. After treatment of Mn, cells lost their normal
spindle-like morphology, shrank or became round. They
were detached and some even ﬂoated into the medium.
Co-treatment with SIL (50 lM) markedly ameliorated
Mn-induced morphological alterations. Cells treated with
SIL alone displayed normal morphology.
Inhibitory Effect of SIL on ROS Production
in Mn-Induced Neuro-2A Cells
Figure 2 presented the inhibitory effect of SIL on ROS
production in Mn-induced Neuro-2A cells. Compared to
control, treatment of Neuro-2A cells with Mn at 200 and
800 lM for 24 h increased ROS by 30 and 40% (P\0.05)
and cellular H2O2 by 140 and 200%, respectively. How-
ever, co- treatment with 50 lM of SIL signiﬁcantly
Neurochem Res (2011) 36:1546–1557 1549
123reduced the levels of Mn-induced ROS and H2O2 produc-
tion (P\0.05) compared to Mn treated cells. There were
no changes in ROS and H2O2 levels after treatment with
50 lM of SIL alone (Fig. 2).
Effect of SIL on Antioxidant Enzyme Activities
in Mn-Induced Neuro-2A Cells
Intracellular levels of antioxidant enzymes such as
Mn-SOD, Cu-Zn SOD, CAT and GPx in Neuro-2A cells
following exposure to MnCl2 and SIL for 24 h were
measured by spectrophotometric analysis (Table 1).
Neuro-2A cells exposed to MnCl2 showed a signiﬁcant
decrease in the speciﬁc activities of Mn-SOD, Cu-Zn SOD,
CAT and GPx when compared to cells treated with a
vehicle control (P\0.05). Whereas, their activity was
increased signiﬁcantly (P\0.05) when Mn-treated cells
were co-cultured with SIL as compared to Mn-treated cells.
Effect of SIL on Lipid Peroxidation Product and Protein
Carbonylation in Mn-Treated Neuro-2A Cells
We tested next the effect of SIL on the lipid peroxidation
product (MDA) and protein carbonyls (PCO) in Mn-treated
cells as presented in Fig. 3. A signiﬁcant increase
(P\0.05) in MDA and PCO levels was observed in Mn-
treated cells compared to a vehicle control. Co-adminis-
tration of Silymarin at 50 lM signiﬁcantly decreased
(P\0.01) the levels of these parameters. Further, there
were no changes in the MDA and protein carbonyl levels
after silymarin treatment as compared to control cells.
Effect of SIL on ATPase Activity in Mn-Induced
Neuro-2A Cells
Table 2 illustrated Na
?-K
?-ATPase and Ca
2? activities
in Neuro-2A cells. Mn exposure caused a signiﬁcant
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Fig. 1 The effect of silymarin on Mn-induced toxicity in Neuro-2A
cells. (a) Dose-dependent effects on cell viability was assessed using
MTT assay. (b) Cell death was quantiﬁed by the release of LDH, from
Neuro-2A cells into the medium treated with Mn and/or various
concentrations of Silymarin exposure for 24 h. (c) The morphology
of the treated cells was examined by phase contrast photomicrography
using olympus inverted microscope. Data represent the group
mean ± SD of 6 independent experiments. *P\0.05, **P\0.01,
***P\0.001 versus vehicle control group.
#P\0.05,
##P\0.01,
###P\0.001 versus Mn-treated alone group
1550 Neurochem Res (2011) 36:1546–1557
123inhibition (P\0.05) in the Na
?-K
?-ATPase and Ca
2?
activities in Neuro-2A cells compared to those of control
group. Co-incubation cells with SIL at 50 lM signiﬁcantly
(P\0.05) ameliorated the decreasing activities of these
enzymes obtained in the Mn-treated cells.
Effect of SIL on Thiol (SH), Disulﬁde (SS) Contents,
as Well as on SH/SS Ratio and GSH in Mn-Treated
Neuro-2A Cells
The in vitro effect of SIL on SH/SS redox status in Mn-
treated cells was studied by measuring thiol and disulﬁde
contents. Table 3 showed that Mn signiﬁcantly decreased
the total thiol content and increased disulﬁde levels in a
dose-dependent manner (P\0.01). The SH/SS ratio was
signiﬁcantly reduced. These effects were signiﬁcantly
mitigated by 50 lM of silymarin compared to those of Mn-
treated cells. These biochemical parameters did not differ
between control and silymarin treated cells.
The effects of varying concentrations of MnCl2 on
intracellular GSH were also evaluated and presented in
Table 3. Mn treatment led to a signiﬁcant decrease in GSH
level (P\0.05) compared to that of control group. Co-
treatment with SIL signiﬁcantly improved GSH levels in
the cell lysates when Neuro-2A cells were treated with Mn
only.
Effect of SIL on MnCl2 Generated of Proinﬂammatory
Cytokines and Nitrite in Neuro-2A Cells Culture
As shown in Fig. 4, and compared to control cultures, no
signiﬁcant release of either TNFa or IL-6 was detected in
the medium of Neuro-2A cells exposed to Mn. Since, the
elevated accumulation of nitrite (P\0.05), in a concen-
tration-dependent manner, was observed compared to a
vehicle control. Co-incubation of Mn treated cells with SIL
signiﬁcantly attenuated NO levels without reaching control
values.
Discussion
Manganese, 1 of the essential elements for the living body,
is required for lipid, protein and carbohydrate metabolism
and also in the function and the development of the brain
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Fig. 2 The effects of silymarin on ROS generation were measured by
increased ﬂuorescence with the DCFH-DA assay (a) as well as on
cellular H2O2 accumulation (b) induced by manganese in Neuro-2A
cells. Cells were co-cultured with Mn (200 and 800 lM) and SIL
(50 lM) for 24 h. The values are mean ± SD of 6 independent
experiments. *P\0.05, **P\0.01, ***P\0.001 versus vehicle
control group.
#P\0.05,
##P\0.01,
###P\0.001 versus Mn-
treated alone group
Table 1 The effects of the Mn exposure (200 and 800 lM) and/or SIL 50 lM on antioxidant enzymes activities in Neuro-2A lysates
Groups
Control SIL50 Mn200 Mn800 Mn200 ? SIL50 Mn800 ? SIL50
Mn-SOD 1.43 ± 0.11 1.34 ± 0.10 0.92 ± 0.17*** 0.77 ± 0.05*** 1.16 ± 0.07
# 1.02 ± 0.09
#
Cu/Zn-SOD 2.23 ± 0.18 2.45 ± 0.17 1.48 ± 0.21*** 1.05 ± 0.12*** 1.8 ± 0.16
# 1.56 ± 0.14
##
CAT 12.75 ± 0.5 13.25 ± 0.44 6.8 ± 0.3*** 6.35 ± 0.7*** 10.1 ± 0.24
### 9.69 ± 0.68
###
GPx 8.84 ± 0.7 8.65 ± 0.91 7.25 ± 0.54** 4.62 ± 0.26*** 6.05 ± 0.3
# 6.00 ± 0.6
#
Data are expressed as Mn-SOD and Cu-Zn SOD (unit/mg protein), CAT (lmole H2O2consumed/min/mg protein) and GPx (nmoles GSH
oxidized/min/mg protein)
Results represent mean ± SD (n = 6)
* P\0.05; ** P\0.01; *** P\0.001 versus vehicle control group
# P\0.05,
## P\0.01,
### P\0.001 versus Mn-treated alone group
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123[38]. Its excessive amounts cause parkinsonian symptoms
and which were implicated in the pathogenesis of Parkin-
son’s disease (PD) via several pathways. In vitro models
represent an effective system for determining the
mechanisms involved in neurodegenerative effects of Mn.
The present study focused on characterising the mode of
cell death in Neuro-2A cells treated with Mn and the pos-
sible mechanisms in neuroprotective effects of silymarin.
To our knowledge, this is the ﬁrst work which showed that
silymarin protected Neuro-2A cells against Mn-induced
ROS generation and glutathione depletion.
Neuronal injury was assessed by measuring MTT and
LDH released activity. The MTT assay has been used to
study neuronal injury, which quantiﬁes mitochondrial
activity by measuring the formation of a dark blue formazan
product formed by the reduction of the tetrazolium ring of
MTT [39] LDH is an indicator of the integrity of cell
membrane, normally existing in the cell was released into
the medium from damaged neurons. In our study, Mn used
at 200 and 800 lM for 24 h induced toxicity of Neuro-2A
cells as evidenced by an increase of Lactate deshydrogenase
(LDH) release and a decrease of cellular viability (MTT
assay) which was supported by morphological examina-
tions. These results are consistent with earlier observations
in other cell types [40–42] corroborating that impairment of
mitochondria function is one of the key mechanisms in Mn
cytotoxicity. However, Gunter et al. [43] demonstrate that
Mn
2?, preferentially accumulated in mitochondria, can
disrupt oxidative phosphorylation and enhances the gener-
ation of reactive oxygen species (ROS). The increase of
ROS, as demonstrated by both DCFH-DA and FOX
detection of cellular H2O2, support these ﬁndings. In our
present study, the co-incubation of Neuro-2A cells with
silymarinprotects them against cytotoxicity induced by Mn.
These observations indicate that the neuroprotective effect
of silymarin, at least partially, is attributed to its antioxidant
and free radical scavenging properties. Similar results
report that silymarin decreases lipid peroxidation, a sensi-
tive marker of oxidative stress, in liver microsome and
isolated hepatocytes [44]. Furthermore, it has been dem-
onstrated that the antioxidative activity of silymarin is
related to the scavenging of free radicals [45, 46].
Oxidative stress occurs when the antioxidant defence
system is overwhelmed by the production of reactive
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Fig. 3 The effects of the Mn exposure (200 and 800 lM) and/or SIL
(50 lM) on MDA and protein carbonyl levels in Neuro-2A lysates.
MDA are expressed as nmol formed/mg protein and protein carbonyl
(nmol DNPH conjugated/mg protein). Results represent mean ± SD
(n = 6). *P\0.05, ** P\0.01, *** P\0.001 versus vehicle
control group.
#P\0.05,
##P\0.01,
###P\0.001 versus Mn-
treated alone group
Table 2 The effects of the Mn exposure (200 and 800 lM) and/or SIL 50 lMo nN a
?-K
?-ATPase and Ca
2?-ATPase activities measured in
Neuro-2A cells’ homogenates
Groups
Control SIL50 Mn200 Mn800 Mn200 ? SIL50 Mn800 ? SIL50
Na
?-K
?-ATPase 7.76 ± 0.17 7.26 ± 0.84 4.40 ± 0.39*** 3..33 ± 0.49*** 5.83 ± 0.45
# 4.62 ± 0.39
#
Ca
2?-ATPase 3.48 ± 0.35 3.72 ± 0.15 2.04 ± 0.12*** 1.10 ± 0.10*** 2.58 ± 0.13
# 1.89 ± 0.8
##
ATPase activities are expressed as lmol Pi/mg protein/h
Results represents mean ± SD (n = 6)
* P\0.05; ** P\0.01; *** P\0.001 versus vehicle control group
# P\0.05,
## P\0.01,
### P\0.001 versus Mn-treated alone group
1552 Neurochem Res (2011) 36:1546–1557
123oxygen species. The latter can induce lipid peroxidation
and protein oxidation, hence potentially causing cell death
[47, 48]. Therefore, increasing the antioxidant capacity of
neurons will provide a potential strategy to protect neurons
from Mn-induced oxidative damage. In this study, cells
treated with Mn increased signiﬁcantly MDA and protein
carbonyl levels with a signiﬁcant depressed level in the
activity of the antioxidant enzymes, including isoforms of
SOD, CAT and GPx in Neuro-2A cells. These results
indicated that the cytotoxic actions of Mn in Neuro-2A
cells were mediated, at least in part, by an oxyradical
mechanism involving overproduction of ROS and down
regulation of certain key antioxidant enzymes. Both events
would lead to oxidative stress in Mn-exposed cells.
Treatment with silymarin improved MDA, protein car-
bonyl levels and antioxidant enzyme activities. Based on
these ﬁndings, it is possible that silymarin might be able to
down regulate Mn-induced oxidative damages through the
inhibition of ROS generation and indirectly by activation
of antioxidative system including GSH biosynthesis. One
of the defense mechanisms that protect the cell from oxi-
dative damage is the dismutation of superoxide anion
radical to hydrogen peroxide by SOD which is further
converted to water by GPx, using GSH as a substrate. The
generated hydrogen peroxide can be converted in sponta-
neous reaction catalyzed by metals such as iron (Fenton
reaction) to the highly reactive hydroxyl radical, reacting
with various biological macromolecules including poly-
unsaturated fatty acids by which the process of lipid per-
oxidation is initiated [49]. In our study, a clear-cut
enhancement of GPx activity caused by SIL might conceal
an expected increase in GSH levels. As a result, this
facilitated defense mechanism shifts the conversion of
hydrogen peroxide to water thereby reducing the formation
of highly reactive hydroxyl radical, and eventually leading
to a lipid peroxidation decrease and hydrogen peroxide
accumulation.
Previous studies demonstrate that hydrogen peroxide
(H2O2) can provoke cellular injuries, including the oxida-
tion of redox sensitive cysteinyl thiols in proteins [50, 51].
In oxidative conditions, S-nitrosation is a reversible mod-
iﬁcation able to protect protein cysteinyl thiols against
unwanted and possibly irreversible oxidation into sulfenic,
sulﬁnic and sulfonic acids and intra/intermolecular disul-
ﬁde bonds [52, 53]. As an abundant cellular antioxidant,
GSH, like its precursors, has a protective action in oxida-
tive stress conditions. In cells, GSH is oxidized to the
GSSG disulﬁde by the action of GSH-peroxidase through a
mechanism that consumes H2O2 [54]. In its S-nitrosated
form, S-nitroso-glutathione (GSNO), GSH could act as a
transporter and a stable reservoir of NO [55], as does Cy-
stein (Cys) [56]. Redox sensitive Cystein residues of cel-
lular proteins (–SH) become S-oxidized (–SOx) providing
an important non-enzymatic cellular means to eliminate
H2O2 [50]. Excessive oxidation can however, severely
damage proteins by the formation of irreversible S-S bonds
and the conversion of SH groups into sulﬁnic and sulfonic
acids. These attacks on sulfhydryls have been detected in
Mn-treated cells. GSH was reported to provide cell pro-
tection possibly by consuming H2O2, generating extracel-
lular GSSG and protein S-glutathionylated adducts (–SSG)
[57] and thus decreasing the amount of oxidant that can
attack sulfhydryls. Considering that the total thiol content
was signiﬁcantly reduced by Mn while disulﬁde levels
were enhanced, a signiﬁcant reduction in SH/SS ratio was
observed, suggesting that Mn was able to disturb the thiol
redox status in Neuro-2A cells lysates. Given the numerous
processes that are dependent upon cellular redox state,
alteration of SH/SS ratio is considered as an important
parameter indicative of oxidative stress. GSH is used to
detoxify ROS and itself is converted to the oxidized form,
GSSG. Our results are in accordance with previous
observation which demonstrates the reduction of total GSH
in the SK-N-SH (neuron-like) cells induced by manganese
Table 3 The effects of the Mn exposure (200 and 800 lM) and/or SIL 50 lM on intracellular GSH concentration, thiol (SH) and disulﬁde (SS)
contents, and SH/SS ratio measured in Neuro-2A cells homogenates
Groups
Control SIL50 Mn200 Mn800 M 200 ? SIL50 Mn800 ? SIL50
GSH 46.44 ± 4.26 45.07 ± 2.13 30.53 ± 3.34*** 22.26 ± 4.37*** 34.92 ± 3.50
### 33.64 ± 3.93
#
SH content 25.38 ± 3.25 25.05 ± 3.17 19.90 ± 0.15*** 16.5 ± 0.49*** 22.40 ± 0.70
# 20.51 ± 0.35
###
SS content 5.43 ± 0.36 5.91 ± 0.35 10.45 ± 0.17*** 14.90 ± 1.25*** 8.25 ± 0.93
## 10.45 ± 0.65
###
SH/SS ratio 4.96 ± 0. 29 5.05 ± 0.25 2.00 ± 0.18*** 1.25 ± 0.40*** 2.48 ± 0.13
# 2.25 ± 0.11
###
Data are expressed as GSH (lmol/10
6cells), SH and SS (nmol TNB/mg protein)
Results represent mean ± SD (n = 6)
* P\0.05; ** P\0.01,; *** P\0.001 versus vehicle control group
# P\0.05,
##P\0.01,
### P\0.001 versus Mn-treated alone group
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123[58]. Several explanations by which silymarin regulates
Mn-induced oxidative stress remain possible: (1) As a
polyphenolic ﬂavonoid, silymarin has a strong free radical-
scavenging activity [46]. It reacts with a damaging free
radical and forms a ﬂavonoid radical, with a great stability
and breaks the free radical chain reaction [59]. SIL, having
potential antioxidative properties is known for its anti-lipid
peroxidative capability against a variety of oxidative stress
and thus can suppress oxidative damage [60–62]. (2) The
neurotoxicity of Mn is mediated by forming H2O2, which
generates lipid peroxidation adducts and protein carbonyl
modiﬁcations in various cellular compartments. Incubation
with the Fe
3? chelator desferrioxamine has been shown to
decrease the toxicity of Mn. It is possible that silymarin
attenuates the Mn-induced oxidative stress by chelating
metal ions [63, 64]. (3) Oxidative stress occurs when the
antioxidative defenses are broken down by the overpro-
duction of reactive oxygen species. Expanding the anti-
oxidant capacity of neuronal cells will provide a potential
strategy to protect neurones from oxidative damage [65,
66]. Silymarin is known to induce the expression of anti-
oxidative enzymes [67, 68]. Therefore, it is possible that
silymarin alleviates oxidative damage indirectly by acti-
vation of antioxidative system including GSH biosynthesis.
Free radicals can attack polyunsaturated fatty acids
(PUFA) in the biomembrane and initiate lipid peroxide
chain reactions, leading to membrane dysfunction thereby
destroying his special arrangement and impairing local
enzyme activities. Na
?-K
?-ATPase, a membrane-bound
enzyme responsible for maintaining Na
? and K
? gradients
across the plasma cell membranes [69], was reported to be
inhibited by ROS in primary cultured neurons [70]. ATP-
driven plasma membrane calcium-pump (Ca
2?-ATPase),
of crucial importance in maintaining a low resting intra-
neuronal Ca
2? particularly in excitable cells such as neu-
rons, is involved in the ﬁnal common pathway leading to
cell death [71]. The decrease in the activities of Na
?-K
?-
ATPase and Ca
2?-ATPase observed in Neuro-2A cells
supports these ﬁndings. Previous studies have found that
Mn
2? could alter the balance between the simultaneous
uptake and release of Ca
2? across the mitochondrial inner
membrane [72]. In fact, it has been shown that oxidative
stress increases intracellular Ca
2? concentrations leading to
activation of endonucleases which degrade DNA and,
ultimately, contribute to cell death. Furthermore, it has
been demonstrated that ROS overproduction may inhibit
Ca
2?-ATPases and lead to alter regulation of Ca
2? levels
and cell death. In the current study, we found that the co-
incubation of Neuro-2A cells with silymarin effectively
alleviated the decline of Na
?-K
?-ATPase and Ca
2?-ATP-
ase activities caused by Mn and subsequently stabilized
transmembrane protein.
Upon activation, Neuro-2A cells secrete numerous bio-
active factors such as interleukins, TNF-a and nitric oxide
(NO). The nature of the released factors appears to be
dependent on the nature of the causative agents. For
example, lipopolysaccharide (LPS) was reported to
increase the release of IL-6, TNF-a and NO [73]. In this
study, NO was released but no signiﬁcant release of cyto-
kines TNFa and IL-6 was detected in Neuro-2A cells
cultures treated with MnCl2 (200, 800 lM). This result is
consistent with ﬁndings reported by others who
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Fig. 4 The effects of the Mn exposure (200 and 800 lM) and/or SIL
(50 lM) on the production of nitrite (a), TNFa (b), and IL-6 (c).
The data are expressed as mean ± SD from triplicate assays.
***P\0.001 versus vehicle control group.
#P\0.05,
###P\
0.001 versus Mn-treated alone group
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123demonstrate that in the mouse N9 microglial cells where no
release of TNF-a, IL-1b and IL-6 was detected after
treatment with MnCl2 at doses lower than 500 lM[ 73].
Moreover, a signiﬁcant accumulation of nitrite was
observed in the Neuro-2A cells cultures following treat-
ment with MnCl2 at two doses used (200, 800 lM). Similar
results were observed in primary mouse astroglia treated
for 8 h with 10 lM MnCl2 [74] or C6 glioma cells treated
for 24 h with 100 lM MnCl2 [75]. Although the NO syn-
thesized by neuronal nitric oxide synthase (NOS) facilitates
the formation of memories under physiological conditions
[76], NO production from inducible nitric oxide synthase
(iNOS) is deleterious under pathological conditions.
Because of its independence of elevated intracellular Ca
2?
levels [77], iNOS catalyzes a high-output pathway of NO
production [78] that is able to cause neuronal peroxynitrite-
mediated damage and dysfunction [79]. Silymarin signiﬁ-
cantly inhibited the increase of extra-cellular nitrite (NO)
as reported by us and suppressed the expression or acti-
vation of iNOS in several tissues including a glial cell line
as it has been reported by others [49, 80].
The results from the present study conﬁrm, for the ﬁrst
time, that silymarin could alleviate the toxicity induced by
Mn in Neuro-2A cells. The beneﬁcial effect may be
attributed to the prevention of oxidative damage, measured
in terms of the amount of peroxidized lipid and the level of
GSH. Currently, the exact mechanism of SIL-induced
neuroprotection and its potential therapeutic applications in
neurodegenerative disorders are still unclear and warrant
further investigations.
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